Metabolife Federal Probe Spurs Release Of Ephedrine Complaint Records
This article was originally published in The Tan Sheet
Executive Summary
An FDA task force will review the 13,000 ephedrine alkaloid patient complaint records Metabolife is releasing in response to publicity surrounding a criminal investigation into whether the company lied about its knowledge of adverse events
You may also be interested in...
Metabolife founder sentenced
Former Metabolife President Michael Ellis is sentenced to six months in prison and ordered to pay a $20,000 fine after pleading guilty to making false statements to federal regulators, according to a judgment filed June 10 in the U.S. District Court for the Southern District of California in San Diego. Ellis told FDA in 1998 that his company had never received any consumer complaints related to its ephedra-containing Metabolife 365. The weight-control supplement firm later released 13,000 patient complaints during a criminal investigation by the Department of Justice (1"The Tan Sheet" Aug. 19, 2002, p. 3)...
Metabolife, Founder Indicted By Jury; Charges “Utterly Baseless,” Firm Says
Metabolife founder Michael Ellis could face up to 40 years in jail and maximum fines of $2 mil. if found guilty of an eight-count indictment laid down in San Diego federal court
Metabolife 356 “Unreasonably Dangerous,” Jury Says In $4.1 Mil. Verdict
Metabolife sold its ephedrine alkaloid-containing Metabolife 356 in a "defective condition unreasonably dangerous to an ultimate user," a Birmingham, Ala. federal jury concluded in four cases Nov. 19